Genelabs
Executive Summary
James Andress, who headed Beecham's worldwide pharmaceutical business prior to the company's merger with SmithKline, named to the board of the privately held biotechnology company. Prior to joining Beecham, Andress served as president and chief operating officer at Sterling Drug. He currently is president and CEO of Information Resources, Inc.
You may also be interested in...
Execs On The Move: Promotions At Agilent And CHF Solutions; New Chief At Zimmer
CHF Solutions adds “CEO” to its president’s job title; Agilent VP of business development promoted to senior VP; Zimmer hires chief transformation officer; and more.
Pfizer’s Pegfilgrastim Biosimilar ‘Has Launched’ In The US
Pfizer has pressed on with the launch of a fourth biosimilar pegfilgrastim product, Nyvepria (pegfilgrastim-apgf), according to an investment bank. With Amgen continuing to hold more than 70% of the market, there is opportunity for Pfizer to capture significant market share.
EU Business Round-Up: Galenica Boosted By Deals, Alliance's Sales Rise, And Beiersdorf Relaunches Wound Care
Latest EU business news: Galenica posts sales up in 2020 thanks to deals; Alliance Pharma's Consumer sales edge up despite COVID-19; and Beiersdorf is relaunching its wound care range with sustainability in mind.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: